Reimagining Kidney Care to Improve Outcomes and Reduce Costs with Chris Riopelle
This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE
—
Episode Overview:
Is it possible to reimagine kidney care to improve outcomes and reduce costs for millions of our fellow Americans?
Our next guest, Chris Riopelle, believes deeply that the answer is yes and he is tackling this challenge as co-founder and CEO of Strive Health.
With over two decades of healthcare leadership experience, Chris brings a unique perspective to transforming kidney care delivery. Driven by a passion to help underserved patients, he’s leading Strive’s innovative approach of combining technology-enabled interventions with local provider integration.
Under Chris’s leadership, Strive has improved care quality while significantly reducing hospitalizations and costs.
While together, Chris shares how Strive Health is partnering with payers and providers to create an integrated care delivery system supporting patients from chronic to end-stage kidney disease.
Join us as we explore how Chris and his team of “Strivers” are pioneering value-based kidney care and reshaping the future of health and care. Let’s go!
Episode Highlights:
- Strive Health’s mission to transform kidney care using advanced data analytics and AI
- The innovative “care multiplier” platform enabling targeted, efficient patient care
- Success in reducing costs, improving patient satisfaction, and extending lives
- Growing importance of specialty value-based care, with kidney care at the forefront
- Future integration of AI in care delivery and increasing patient readiness for new care models
About our Guest:
Chris Riopelle is the co-founder and CEO of Strive Health, a value-based kidney care company. He leads the company in its efforts to improve the lives of underserved patients living with kidney disease – from chronic through end-stage. Strive Health supports 110,000 patients across 50 states with $3.8 billion in medical spend under management. Founded in 2018, Strive is home to 700 “Strivers” and has been recognized multiple times as a best place to work. Chris and Strive are proud to be partnered with blue chip investors such as NEA, CapitalG (Alphabet), CVS Health Ventures, and Town Hall Ventures.
In his role as CEO, Chris works to drive value for patients, providers and payors by transforming how kidney care is delivered in the U.S. Under his leadership, Strive Health’s innovative clinical model has improved care quality and reduced hospital admissions by nearly 50%, re-admissions by 30% and total cost of care by 20%.
Chris was recognized as a Denver Business Journal Most Admired CEO in 2023 and was named an E&Y Entrepreneur of the Year in 2021. Chris started his career in healthcare at GeriMed, a company that sparked his interest in underserved populations and risk-bearing healthcare businesses. He spent 10 years in the kidney care industry at Gambro and DaVita, culminating in leading a $1 billion division of DaVita. Chris also served as COO of LaVie Care Centers, a $1 billion skilled nursing company, where he led the turnaround and successful exit of the business. He was also CEO of NorthStar Anesthesia, an anesthesia management company that grew from $130 million to $500 million in revenue under his leadership. Chris has a BA in Economics from Albion College and holds a JD/MBA from the University of Detroit Mercy.
Links Supporting This Episode:
- Strive Health Website: CLICK HERE
- Chris Riopelle LinkedIn page: CLICK HERE
- Strive Health LinkedIn page: CLICK HERE
- Mike Biselli LinkedIn page: CLICK HERE
- Mike Biselli Twitter page: CLICK HERE
- Visit our website: CLICK HERE
- Subscribe to newsletter: CLICK HERE
- Guest nomination form: CLICK HERE
